Andrew A Protter Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Andrew A Protter.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Andrew A Protter. Andrew A Protter is a VP, Preclinical Development in MEDIVATION, INC. ($MDVN).
Address: C/O MEDIVATION, INC. 201 SPEAR STREET, 3RD FLOOR SAN FRANCISCO 94105 CA
Companies in which Andrew A Protter is an Insider
MEDIVATION, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Andrew A Protter: VP, Preclinical Development
Holdings: 0 shares
Latest Transaction: Nov 03 2008
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Andrew A Protter
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 03 2008 | MDVN | MEDIVATION, INC. | Protter Andrew A | VP, Preclinical Dev ... | Option Exercise | A | 18.77 | 14,510 | 272,353 | 14,510 | |
| Sep 10 2008 | MDVN | MEDIVATION, INC. | Protter Andrew A | VP, Preclinical Dev ... | Option Exercise | M | 5.35 | 16,000 | 85,600 | 201,000 | |
| Sep 10 2008 | MDVN | MEDIVATION, INC. | Protter Andrew A | VP, Preclinical Dev ... | Option Exercise | M | 5.35 | 6,850 | 36,648 | 217,000 | |
| Sep 10 2008 | MDVN | MEDIVATION, INC. | Protter Andrew A | VP, Preclinical Dev ... | Option Exercise | M | 5.35 | 1,150 | 6,153 | 223,850 | |
| Sep 10 2008 | MDVN | MEDIVATION, INC. | Protter Andrew A | VP, Preclinical Dev ... | Sell | S | 31.85 | 16,000 | 509,579 | 0 | 16 K to 0 (-100.00 %) |
| Sep 10 2008 | MDVN | MEDIVATION, INC. | Protter Andrew A | VP, Preclinical Dev ... | Buy | M | 5.35 | 16,000 | 85,600 | 16,000 | 0 to 16 K |
| Sep 10 2008 | MDVN | MEDIVATION, INC. | Protter Andrew A | VP, Preclinical Dev ... | Sell | S | 25.00 | 6,850 | 171,250 | 0 | 6.9 K to 0 (-100.00 %) |